IND application submitted by CBCC

We are excited to announce that we have reached a significant milestone!

IND application submitted by CBCC, acting as a US agent for a Biotech company, was accepted by USFDA and applicant has received ‘STUDY MAY PROCEED’ letter!

Type of application: 505(b)(1)

Therapeutic Area: Oncology

Scope: End-to-end regulatory services.
We are now gearing up for the FIH trial in the US!

CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News & Events

Latest News

IND application submitted by CBCC

CBCC Global Research

CBCC Global Research